|
2026 Journal Article Response to: Correspondence on “Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intrauterine device for endometrial hyperplasia and adenocarcinoma – Results from the feMMe phase 2 randomized clinical trial” by Baxter et alBaxter, Eva, Robledo, Kristy P., Janda, Monika and Obermair, Andreas (2026). Response to: Correspondence on “Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intrauterine device for endometrial hyperplasia and adenocarcinoma – Results from the feMMe phase 2 randomized clinical trial” by Baxter et al. International Journal of Gynecological Cancer 104757, 104757. doi: 10.1016/j.ijgc.2026.104757 |
|
2026 Journal Article Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intrauterine device for endometrial hyperplasia and adenocarcinoma – Results from the feMMe phase 2 randomized clinical trialBaxter, Eva, Robledo, Kristy P., Janda, Monika and Obermair, Andreas (2026). Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intrauterine device for endometrial hyperplasia and adenocarcinoma – Results from the feMMe phase 2 randomized clinical trial. International Journal of Gynecological Cancer, 36 (7) 104725, 104725. doi: 10.1016/j.ijgc.2026.104725 |
|
2026 Journal Article Changes and trends in endometrial cancer patterns of care: a scoping review of the literature from 2000 to 2024Yu, Michael, Baxter, Eva and Obermair, Andreas (2026). Changes and trends in endometrial cancer patterns of care: a scoping review of the literature from 2000 to 2024. International Journal of Gynecological Cancer, 36 (4) 104614, 1-11. doi: 10.1016/j.ijgc.2026.104614 |
|
2026 Journal Article Effects of exercise therapy during chemotherapy for ovarian cancer on progression-free survival and physical wellbeing (ECHO trial)Spence, Rosa, Obermair, Andreas, Davis, Alison, Brand, Alison, Barnes, Elizabeth, Andrews, John, O'Neille, Helene, Collins, Louisa, Williams, Merran, Lee, Yeh Chen, Stockler, Martin and Hayes, Sandra (2026). Effects of exercise therapy during chemotherapy for ovarian cancer on progression-free survival and physical wellbeing (ECHO trial). Journal of Clinical Exercise Physiology, 15 (s2), 241-241. doi: 10.31189/2165-7629-15-s2.241 |
|
2026 Journal Article Response to: considerations on interpreting temporal trends in a scoping review of endometrial cancer careYu, Michael, Baxter, Eva and Obermair, Andreas (2026). Response to: considerations on interpreting temporal trends in a scoping review of endometrial cancer care. International Journal of Gynecological Cancer 104720, 104720. doi: 10.1016/j.ijgc.2026.104720 |
|
2026 Journal Article Sentinel lymph node biopsy compared to no nodal assessment in endometrial cancer: a systematic reviewObermair, Helena M., Mathew, Alwyn, Zand, Behrouz and Obermair, Andreas (2026). Sentinel lymph node biopsy compared to no nodal assessment in endometrial cancer: a systematic review. International Journal of Gynecological Cancer, 36 (3) 102870. doi: 10.1016/j.ijgc.2025.102870 |
|
2026 Journal Article Efficacy of ultrasound in the evaluation of inguinal lymph nodes in patients with vulvar cancer: an updated systematic review and meta-analysisKing, Abigail, Harris, William, Campbell, Zara, Hazelton, Annabelle and Obermair, Andreas (2026). Efficacy of ultrasound in the evaluation of inguinal lymph nodes in patients with vulvar cancer: an updated systematic review and meta-analysis. International Journal of Gynecological Cancer, 36 (2) 102865. doi: 10.1016/j.ijgc.2025.102865 |
|
2026 Journal Article Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: a Society of Gynecologic Oncology clinical practice statementSalani, Ritu, Atallah, David, Fader, Amanda N., Frimer, Marina, Obermair, Andreas, Pareja, Rene and Huang, Marilyn (2026). Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: a Society of Gynecologic Oncology clinical practice statement. Gynecologic Oncology, 204, 109-117. doi: 10.1016/j.ygyno.2025.11.014 |
|
2026 Journal Article Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trialVirili, Florencia, Obermair, Andreas, Sanjida, Saira, Nicklin, James L., Garrett, Andrea, Land, Russell, Tang, Amy, Campbell, Louise, Gebski, Val and Thomas, Paul (2026). Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial. International Journal of Gynecologic Cancer, 36 (1) 101854, 1-9. doi: 10.1136/ijgc-2024-005633 |
|
2026 Journal Article Sentinel lymph node biopsy in vulvar cancer: current evidence, limitations, and future perspectivesBogani, Giorgio, Obermair, Andreas, Testa, Antonia, Gargenese, Giorgia, Chiappa, Valentina, Raspagliesi, Francesco and Hacker, Neville (2026). Sentinel lymph node biopsy in vulvar cancer: current evidence, limitations, and future perspectives. Journal of Gynecologic Oncology, 37 e110. doi: 10.3802/jgo.2026.37.e110 |
|
2025 Journal Article Extracellular vesicles as biomarkers for endometrial cancer – a systematic reviewBaxter, Eva, Nair, Soumyalekshmi, West, Zoe, Salomon, Carlos and Obermair, Andreas (2025). Extracellular vesicles as biomarkers for endometrial cancer – a systematic review. Translational Oncology, 62 102543, 1-10. doi: 10.1016/j.tranon.2025.102543 |
|
2025 Journal Article Subjective assessment of adnexal masses using various ultrasonographic diagnostic models: an analysis of interobserver variabilityRizzuto, Ivana, Rezai, Shohreh, Lane, Annah, Prior, Marita, Robledo, Kristy P. and Obermair, Andreas (2025). Subjective assessment of adnexal masses using various ultrasonographic diagnostic models: an analysis of interobserver variability. Australian and New Zealand Journal of Obstetrics and Gynaecology, 65 (6), 792-799. doi: 10.1111/ajo.70036 |
|
2025 Journal Article Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trialBaxter, Eva, Robledo, Kristy P., Cummings, Margaret, Alizart, Michelle, Smith, Deborah and Obermair, Andreas (2025). Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial. American Journal of Surgical Pathology, 50 (2), 259-266. doi: 10.1097/pas.0000000000002492 |
|
2025 Journal Article Long-term oncological and fertility outcomes following the levonorgestrel intrauterine device in early-stage endometrial adenocarcinoma – results from the Femme phase II randomised trialBaxter, Eva, Robledo, Kristy, Gebski, Val, Chen, Chen, Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James, Chetty, Naven, Janda, Monika and Obermair, Andreas (2025). Long-term oncological and fertility outcomes following the levonorgestrel intrauterine device in early-stage endometrial adenocarcinoma – results from the Femme phase II randomised trial. International Journal of Gynecological Cancer, 35 (11) 102239. doi: 10.1016/j.ijgc.2025.102239 |
|
2025 Journal Article Diet and lifestyle quality in Australian women with endometrial cancer at diagnosis – insights from the FeMMe trialAl Ramadhani, Ruqaiya, Janda, Monika, Playdon, Mary and Obermair, Andreas (2025). Diet and lifestyle quality in Australian women with endometrial cancer at diagnosis – insights from the FeMMe trial. Current Developments in Nutrition, 9 (12) 107572, 1-10. doi: 10.1016/j.cdnut.2025.107572 |
|
2025 Conference Publication Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: results from the International Vulvar Cancer ConsortiumNasioudis, Dimitrios, Wohlmuth, Christoph, Albright, Benjamin, McDonald, Megan, Wallace, Sumer, Glickman, Ariel, Do, Anthony, Mantia-Smaldone, Gina, Grassi, Tommaso, Fleming, Elaine, Tsibulak, Irina, Reis, Ricardo Dos, Cucinella, Giuseppe, Heredia, Fernando, Pereira, Augusto, Bogani, Giorgio, Buckingham, Lindsey, Baiocchi, Glauco, Mills, Kathryn, AlHilli, Mariam, Obermair, Andreas, Covens, Allan, Mariani, Andrea, Plante, Marie and Giuntoli, Robert (2025). Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: results from the International Vulvar Cancer Consortium. 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer, Seattle, WA USA, 14-17 March 2025. Maryland Heights, MO USA: Academic Press. doi: 10.1016/j.ygyno.2025.03.075 |
|
2025 Journal Article Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001677), (10.1016/j.ijgc.2025.101644))Obermair, Andreas, Gebski, Val, Goh, Jeffrey, Kuchel, Anna, Brand, Alison, Mak, Blossom, McNally, Orla, Baxter, Eva, Jobling, Thomas and Mileshkin, Linda (2025). Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001677), (10.1016/j.ijgc.2025.101644)). International Journal of Gynecological Cancer, 35 (9) 101961, 1-2. doi: 10.1016/j.ijgc.2025.101961 |
|
2025 Conference Publication A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancerCohen, P.A., Obermair, A., Gebski, V., King, M.T., Butow, P., Campbell, R., Bilic, S., Brand, A., Codde, J., Goh, J.C.H., Ives, A., Kiberu, A.D., Lawson, W., Mellon, A., McNally, O., Meniawy, T., Mileshkin, L., Morton, R., Webb, P. and Friedlander, M.L. (2025). A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer. ESMO Congress 2025, Berlin, Germany, 17-21 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2025.08.1166 |
|
2025 Journal Article Patterns of care for vulval cancer treatment: the Queensland experienceDavie, Stacey, Obermair, Andreas and West, Zoe Elizabeth (2025). Patterns of care for vulval cancer treatment: the Queensland experience. International Journal of Gynecological Cancer, 35 (7) 101956, 101956-101956. doi: 10.1016/j.ijgc.2025.101956 |
|
2025 Journal Article Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgeryWest, Simon, Jayasinghe, Dilki, Davie, Stacey and Obermair, Andreas (2025). Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery. International Journal of Gynecological Cancer, 35 (8) 101993. doi: 10.1016/j.ijgc.2025.101993 |
